Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03547999
Title A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Darren Carpizo, MD
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin

CV301 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Miami Miami Florida 33136 United States Details
University of Kansas Medical Center Research Institute, Inc. Westwood Kansas 66205 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field